STOCK TITAN

[144] SOPHiA GENETICS SA SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Jurgi Camblong reported multiple planned sales of Common Stock under a Rule 10b5-1 plan. The filing lists discrete 10b5-1 sale transactions across 2026 (example: 37,299 shares on 01/22/2026 for $209,917.83) and shows Restricted Stock Units (4,486) and Founders Shares (8,500) referenced.

Positive

  • None.

Negative

  • None.

Insights

Series of pre‑arranged 10b5‑1 dispositions reported; routine compliance filing.

The entries list repeated 10b5‑1 sales by Jurgi Camblong across multiple dates in 2026 with per‑trade share counts and gross proceeds. The filing also records RSUs (4,486) and Founders Shares (8,500) in the securities table.

These entries document sales activity under an automated plan; cash‑flow recipients and any post‑transaction holdings are not provided in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature